BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 8163252)

  • 41. Pravastatin and gemfibrozil alone and in combination for the treatment of hypercholesterolemia.
    Wiklund O; Angelin B; Bergman M; Berglund L; Bondjers G; Carlsson A; Lindén T; Miettinen T; Odman B; Olofsson SO
    Am J Med; 1993 Jan; 94(1):13-20. PubMed ID: 8420296
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.
    Shepherd J; Cobbe SM; Ford I; Isles CG; Lorimer AR; MacFarlane PW; McKillop JH; Packard CJ
    N Engl J Med; 1995 Nov; 333(20):1301-7. PubMed ID: 7566020
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II).
    Byington RP; Furberg CD; Crouse JR; Espeland MA; Bond MG
    Am J Cardiol; 1995 Sep; 76(9):54C-59C. PubMed ID: 7572688
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognosis of hypercholesterolemic patients taking pravastatin for five years: the Chiba Lipid Intervention Program (CLIP) Study.
    Saito Y; Shirai K; Sasaki N; Shinomiya M; Yoshida S;
    J Atheroscler Thromb; 2002; 9(2):99-108. PubMed ID: 12236319
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of cholesterol lowering on plasma membrane lipids and cationic transport systems.
    Lijnen P; Celis H; Fagard R; Staessen J; Amery A
    J Hypertens; 1994 Jan; 12(1):59-64. PubMed ID: 8157945
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS).
    Jukema JW; Bruschke AV; van Boven AJ; Reiber JH; Bal ET; Zwinderman AH; Jansen H; Boerma GJ; van Rappard FM; Lie KI
    Circulation; 1995 May; 91(10):2528-40. PubMed ID: 7743614
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): reduction in atherosclerosis progression and clinical events. PLAC I investigation.
    Pitt B; Mancini GB; Ellis SG; Rosman HS; Park JS; McGovern ME
    J Am Coll Cardiol; 1995 Nov; 26(5):1133-9. PubMed ID: 7594023
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Flaxseed in pediatric hyperlipidemia: a placebo-controlled, blinded, randomized clinical trial of dietary flaxseed supplementation for children and adolescents with hypercholesterolemia.
    Wong H; Chahal N; Manlhiot C; Niedra E; McCrindle BW
    JAMA Pediatr; 2013 Aug; 167(8):708-13. PubMed ID: 23733031
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modulation of lipoprotein(a) atherogenicity by high density lipoprotein cholesterol levels in middle-aged men with symptomatic coronary artery disease and normal to moderately elevated serum cholesterol. Regression Growth Evaluation Statin Study (REGRESS) Study Group.
    Cobbaert C; Jukema JW; Zwinderman AH; Withagen AJ; Lindemans J; Bruschke AV
    J Am Coll Cardiol; 1997 Nov; 30(6):1491-9. PubMed ID: 9362407
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of 6 months of treatment with pravastatin on serum adiponection concentrations in Japanese patients with coronary artery disease and hypercholesterolemia: a pilot study.
    Sakamoto K; Sakamoto T; Ogawa H;
    Clin Ther; 2006 Jul; 28(7):1012-21. PubMed ID: 16990079
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Beneficial effects of pravastatin on fasting hyperinsulinemia in elderly hypertensive hypercholesterolemic subjects.
    Chan P; Tomlinson B; Lee CB; Pan WH; Lee YS
    Hypertension; 1996 Oct; 28(4):647-51. PubMed ID: 8843892
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diet and pravastatin in moderate hypercholesterolaemia: a randomized trial in 215 middle-aged men free from cardiovascular disease.
    Bak AA; Huizer J; Leijten PA; Rila H; Grobbee DE
    J Intern Med; 1998 Nov; 244(5):371-8. PubMed ID: 9845852
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A multicenter comparative trial of lovastatin and pravastatin in the treatment of hypercholesterolemia. The Lovastatin Pravastatin Study Group.
    Am J Cardiol; 1993 Apr; 71(10):810-5. PubMed ID: 8456759
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [A comparison between lovastatin and pravastatin--effects on lipids, sleep and quality of life in primary hyperlipidemia].
    Tonstad S; Gørbitz C; Ose L; Malt UF
    Tidsskr Nor Laegeforen; 1994 Aug; 114(19):2262-4. PubMed ID: 7992293
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial.
    Lewis SJ; Moye LA; Sacks FM; Johnstone DE; Timmis G; Mitchell J; Limacher M; Kell S; Glasser SP; Grant J; Davis BR; Pfeffer MA; Braunwald E
    Ann Intern Med; 1998 Nov; 129(9):681-9. PubMed ID: 9841599
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term assessment of psychological well-being in a randomized placebo-controlled trial of cholesterol reduction with pravastatin. The LIPID Study Investigators.
    Stewart RA; Sharples KJ; North FM; Menkes DB; Baker J; Simes J
    Arch Intern Med; 2000 Nov; 160(20):3144-52. PubMed ID: 11074745
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lactobacillus effects on cholesterol: in vitro and in vivo results.
    Lin SY; Ayres JW; Winkler W; Sandine WE
    J Dairy Sci; 1989 Nov; 72(11):2885-99. PubMed ID: 2516523
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The efficacy and safety of pravastatin in patients aged 60 to 85 years with low-density lipoprotein cholesterol > 160 mg/dl.
    Glasser SP; DiBianco R; Effron BA; Faas F; Germino FW; Shane LE; Unger AH; Staggers JE
    Am J Cardiol; 1996 Jan; 77(1):83-5. PubMed ID: 8540464
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of pravastatin on serum lipids and apolipoproteins in hyperlipidemia of the nephrotic syndrome.
    Tokoo M; Oguchi H; Terashima M; Tokunaga S; Miyasaka M; Hora K; Higuchi M; Yoshie T; Furuta S
    Nihon Jinzo Gakkai Shi; 1992 Apr; 34(4):397-403. PubMed ID: 1635284
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Urapidil in hypercholesterolemic hypertensive patients.
    Ferrara LA; Leonetti G; Fogari R; Mazzola C; Mancini M; Zanchetti A
    Blood Press Suppl; 1994; 4():39-44. PubMed ID: 7804511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.